Majority of the existing antibiotics are ineffective against latest multidrug resistant bacteria. Though several alternatives have been made, none of them are effective in translating into clinical applications. At Nanomicrobe we have developed a new class of antibiotic-alternatives. Our antibacterials are bypass resistant mechanisms due to unique mode of action.

We have developed and continuously updating our portfolio of antibacterials a novel alternatives to antibiotics. Our antibacterial molecules are compatible for both topical and systemic use.